Article Versions Notes

Fernandes CYM, Hirata BKB, Vitiello GAF, Castilha EP, de Sousa-Pereira N, Guembarovski RL, Amarante MK, Watanabe MAE, Aoki MN, de Oliveira KB. Male Sex as a Predictor of Worse Prognosis and Clinical Evolution in Patients with Cancer and SARS-CoV-2 Infection, Independent of the rs41386349 PDCD1 Polymorphism. COVID. 2025; 5(7):104. https://doi.org/10.3390/covid5070104

Fernandes, Caroline Yukari Motoori, Bruna Karina Banin Hirata, Glauco Akelinghton Freire Vitiello, Eliza Pizarro Castilha, Nathália de Sousa-Pereira, Roberta Losi Guembarovski, Marla Karine Amarante, Maria Angelica Ehara Watanabe, Mateus Nóbrega Aoki, and Karen Brajão de Oliveira. 2025. "Male Sex as a Predictor of Worse Prognosis and Clinical Evolution in Patients with Cancer and SARS-CoV-2 Infection, Independent of the rs41386349 PDCD1 Polymorphism" COVID 5, no. 7: 104. https://doi.org/10.3390/covid5070104

Fernandes, C. Y. M., Hirata, B. K. B., Vitiello, G. A. F., Castilha, E. P., de Sousa-Pereira, N., Guembarovski, R. L., Amarante, M. K., Watanabe, M. A. E., Aoki, M. N., & de Oliveira, K. B. (2025). Male Sex as a Predictor of Worse Prognosis and Clinical Evolution in Patients with Cancer and SARS-CoV-2 Infection, Independent of the rs41386349 PDCD1 Polymorphism. COVID, 5(7), 104. https://doi.org/10.3390/covid5070104